HDFC Mid-Cap Opportunities Fund (G) 1560.15 1,33,12,972 2.12 HDFC Mid-Cap Opportunities Fund (IDCW) 1560.15 1,33,12,972 2.12 HDFC Mid-Cap Opportunities Fund - Direct ...

Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of US ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Aurobindo Pharma’s Q3FY25 performance was below our expectation due to lower-than-anticipated sales in US while Europe (up 22.7% YoY) and growth markets (up 39.2% YoY) maintained traction ...

This is to inform you that Unit 2 of Apitoria Pharma Pvt.Ltd., received EIR from USFDA with VAI classification.